Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasibility Trial of the MyJourney Web App: Supporting Adjustment to an Unfulfilled Wish for Children.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04850482
Recruitment Status : Active, not recruiting
First Posted : April 20, 2021
Last Update Posted : August 3, 2021
Sponsor:
Collaborators:
Portuguese Fertility Association
Fertility Network UK
Information provided by (Responsible Party):
Sofia Gameiro, Cardiff University

Brief Summary:

A bilingual online self-help app - MyJourney - has been developed for individuals faced with an unfulfilled wish for children. The specific aim of this trial is to evaluate the feasibility, defined here as determining whether the intervention itself and the study procedures are appropriate for further evaluation, and how users react to the intervention, which will inform the implementation of a future full scale RCT to evaluate MyJourney's efficacy.

This RCT will be a two arm, parallel-group, non-blind feasibility trial with 1:1 allocation to the intervention group (immediate access to MyJourney) or waitlist control group (receives access to MyJourney after 10 weeks). A minimum number of 152 individuals will be enrolled in this study. Once participants have met the eligibility criteria and completed the baseline assessment, they will be randomly assigned to one of two groups: the intervention group or the waitlist control group. The sample will be recruited online.

Participation in this study will last 10 weeks for the waitlist group and 6 months for the intervention group. Participants in both groups will be invited to complete a baseline assessment (online survey) and a follow-up assessment (online survey) at 10-weeks post baseline. The intervention group will also be invited to complete another follow-up assessment at 6-months post baseline. Assessments will include self-report questionnaires to cover socio-demographic information (baseline only), psychological mediators (mechanisms of change) (baseline and 10-week follow-up), psychological outcome questionnaires (baseline, 10-week and 6-month follow up), and questions about acceptability and feasibility (10-week and 6-month follow up).


Condition or disease Intervention/treatment Phase
Mental Health Other: MyJourney Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 221 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Two arm, parallel-group, non-blind feasibility trial with 1:1 allocation to the intervention group (immediate access to MyJourney) or waitlist control group (receives access to MyJourney after 10 weeks).
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Feasibility Randomised Controlled Trial of the MyJourney Web App, Supporting Adjustment to an Unfulfilled Wish for Children.
Actual Study Start Date : November 6, 2020
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : September 2021

Arm Intervention/treatment
Experimental: Intervention Arm
Participants get immediate access to the intervention on completion of baseline assessment.
Other: MyJourney
MyJourney is an online self-help interactive program based on Contextual Cognitive Behavioural Therapy.

No Intervention: Wait list control Arm
Participants get access to the intervention in 10 weeks after completion of the baseline and follow up assessment.



Primary Outcome Measures :
  1. Acceptability of intervention: data directly from web app and survey questions. [ Time Frame: Measured at post-intervention (10 weeks) ]
    Measured through website utilization (e.g. number of visits to app, visit duration, number of steps completed, time spent on each step, number of visits to Routines, time spent at each Routine, Routines marked as favourites by users, ratings of usefulness and challenge of each step) and specific questions (developed by researchers).

  2. Acceptability of intervention: data directly from web app and survey questions. [ Time Frame: Measured at post-intervention (6 months) ]
    Measured through website utilization (e.g. number of visits to app, visit duration, number of steps completed, time spent on each step, number of visits to Routines, time spent at each Routine, Routines marked as favourites by users, ratings of usefulness and challenge of each step) and specific questions (developed by researchers).

  3. Acceptability of study procedures. [ Time Frame: Measured at post-intervention (10 weeks) ]

    Measured through specific questions (developed by researchers) to assess acceptability and proportion of completed online surveys.

    Reasons for non-participation or withdrawal.


  4. Combined demand of intervention and study procedures. [ Time Frame: Measured at post-intervention (10 weeks) ]
    Measured with recruitment and attrition rates (including reported reasons for non-participation or withdrawal).

  5. Combined demand of intervention and study procedures. [ Time Frame: Measured at post-intervention (6 months) ]
    Measured with recruitment and attrition rates (including reported reasons for non-participation or withdrawal).

  6. Implementation of intervention and study procedures reports. [ Time Frame: Measured at post-intervention (10 weeks) ]
    Measured with number of reports of inability to access MyJourney or complete steps or any other questions affecting implementation or reports of problems receiving invitations and accessing the online questionnaires.

  7. Implementation of intervention and study procedures reports. [ Time Frame: Measured at post-intervention (6 months) ]
    Measured with number of reports of inability to access MyJourney or complete steps or any other questions affecting implementation or reports of problems receiving invitations and accessing the online questionnaires.

  8. Practicalities of intervention. [ Time Frame: Measured at post-intervention (10 weeks) ]
    Measured with time for participants to work through all steps in intervention.

  9. Practicalities of intervention. [ Time Frame: Measured at post-intervention (6 months) ]
    Measured with time for participants to work through all steps in intervention.

  10. Practicalities of study procedures. [ Time Frame: Measured at post-intervention (10 weeks) ]
    Measured with length of time for researchers to administer (including time taken to send all required reminders and time taken to respond to emails and respond to queries from participants.

  11. Practicalities of study procedures. [ Time Frame: Measured at post-intervention (6 months) ]
    Measured with length of time for researchers to administer (including time taken to send all required reminders and time taken to respond to emails and respond to queries from participants.

  12. Adaption of study procedures. [ Time Frame: Measured at post-intervention (10 weeks) ]
    Measured with reports of different strategies (e.g. dissemination, recruitment, query resolution) required for Portugal (PT) and United Kingdom (UK).

  13. Adaption of study procedures. [ Time Frame: Measured at post-intervention (6 months) ]
    Measured with reports of different strategies (e.g. dissemination, recruitment, query resolution) required for Portugal (PT) and United Kingdom (UK).

  14. Limited Efficacy Testing - changes from baseline in mental health [ Time Frame: From baseline to 10 weeks. ]
    Measured with the Mental Health Inventory-5 (MHI-5; Veit and Ware, 1983). The total scores range from 1 to 100, with higher scores indicating higher mental health.

  15. Limited Efficacy Testing - changes from baseline in mental health [ Time Frame: From baseline to 6 months. ]
    Measured with the Mental Health Inventory-5 (MHI-5; Veit and Ware, 1983). The total scores range from 1 to 100, with higher scores indicating higher mental health.

  16. Limited Efficacy Testing - changes from baseline in hedonic wellbeing [ Time Frame: From baseline to 10 weeks. ]
    Measured with the World Health Organisation - Five Wellbeing Index (WHO-5; Topp et al., 2015). The total score ranges between 0 to 25, is multiplied by 4 to give the final score, with 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being.

  17. Limited Efficacy Testing - changes from baseline in hedonic wellbeing [ Time Frame: From baseline to 6 months. ]
    Measured with the World Health Organisation - Five Wellbeing Index (WHO-5; Topp et al., 2015). The total score ranges between 0 to 25, is multiplied by 4 to give the final score, with 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being.

  18. Limited Efficacy Testing - changes from baseline in eudaimonic wellbeing [ Time Frame: From baseline to 10 weeks. ]
    Measured with the Office of National Statistics eudaimonic subjective well-being scale (Office of National Statistics, 2012). The total scores range between 0 and 10 with higher scores indicating higher eudaimonic wellbeing.

  19. Limited Efficacy Testing - changes from baseline in eudaimonic wellbeing [ Time Frame: From baseline to 6 months. ]
    Measured with the Office of National Statistics eudaimonic subjective well-being scale (Office of National Statistics, 2012). The total scores range between 0 and 10 with higher scores indicating higher eudaimonic wellbeing.

  20. Limited Efficacy Testing - changes from baseline in posttraumatic growth [ Time Frame: From baseline to 10 weeks. ]
    Measured with the Posttraumatic growth inventory short form (PTG-SF; Cann et al., 2009). The total scores range from 0 to 50, with higher scores indicating higher posttraumatic growth.

  21. Limited Efficacy Testing - changes from baseline in posttraumatic growth [ Time Frame: From baseline to 6 months. ]
    Measured with the Posttraumatic growth inventory short form (PTG-SF; Cann et al., 2009). The total scores range from 0 to 50, with higher scores indicating higher posttraumatic growth.

  22. Limited Efficacy Testing - changes from baseline in happiness [ Time Frame: From baseline to 10 weeks. ]
    Measured with the single item happiness scale (Ahrendt et al., 2017). The total scores range from 1 to 10, with higher scores indicating higher levels of happiness.

  23. Limited Efficacy Testing - changes from baseline in happiness [ Time Frame: From baseline to 6 months. ]
    Measured with the single item happiness scale (Ahrendt et al., 2017). The total scores range from 1 to 10, with higher scores indicating higher levels of happiness.

  24. Limited Efficacy Testing - changes from baseline in satisfaction with life [ Time Frame: From baseline to 10 weeks. ]
    Measured with the single item satisfaction with life scale (Ahrendt et al., 2017). The total scores range from 1 to 10, with higher scores indicating higher satisfaction with life.

  25. Limited Efficacy Testing - changes from baseline in satisfaction with life [ Time Frame: From baseline to 6 months. ]
    Measured with the single item satisfaction with life scale (Ahrendt et al., 2017). The total scores range from 1 to 10, with higher scores indicating higher satisfaction with life.


Secondary Outcome Measures :
  1. Changes from baseline in acceptance [ Time Frame: From baseline to 10 weeks. ]
    Measured with the SCREENIVF Questionnaire (partial) (Verhaak et al., 2010). The total score ranges between 6 to 24, with higher scores indicating higher acceptance.

  2. Changes from baseline in self-compassion [ Time Frame: From baseline to 10 weeks. ]

    Measured with the self-compassion scale short form (SCS-SF; Raes et al., 2011). The total score ranges between 1 and 48, with higher scores indicating higher self-compassion.

    Openness to experience subscale-Comprehensive Assessment of Acceptance and Commitment Therapy processes (CompACT) (Francis et al., 2016)


  3. Changes from baseline in openness to experience (acceptance and defusion) [ Time Frame: From baseline to 10 weeks. ]
    Measured with the Openness to experience subscale-Comprehensive Assessment of Acceptance and Commitment Therapy processes (CompACT; Francis et al., 2016). The total score ranges from 0 to 70, with higher scores indicating higher openness to experience.

  4. Changes from baseline in positive reframing coping [ Time Frame: From baseline to 10 weeks. ]

    Measured with the Brief COPE Inventory (partial) (Carver, Scheier, & Weintraub, 1989).The total score ranges from 1 to 16, with higher scores indicating higher positive reframing coping.

    Motivation and activation subscale-CompACT (Francis et al., 2016)


  5. Changes from baseline in valued action [ Time Frame: From baseline to 10 weeks. ]
    Measured with the Motivation and activation subscale-Comprehensive Assessment of Acceptance and Commitment Therapy processes (CompACT; Francis et al., 2016). The total score ranges from 0 to 48, with higher scores indicating higher valued action.

  6. Changes from baseline in goal re-engagement [ Time Frame: From baseline to 10 weeks. ]

    Measured with the goal re-engagement scale (Wrosch, Scheier, Carver, & Schulz, 2003). The total score ranges from 6 and 30, with higher scores indicating greater engagement in other meaningful life goals

    Committed action scale (CAQ-8) (McCracken, Chilcot, & Norton, 2015)


  7. Changes from baseline in committed action [ Time Frame: From baseline to 10 weeks. ]
    Measured with the Committed action scale (CAQ-8; McCracken, Chilcot, & Norton, 2015). The total score ranges from 0 to 48, with higher scores indicating higher committed action.

  8. Changes from baseline in social connection [ Time Frame: From baseline to 10 weeks. ]
    Measured with the Fertility Problem Inventory - social concern subscale (Newton, Sherrard, & Glavac, 1999). The total score ranges from 1 to 60, with higher scores indicating higher perceived social connection.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • able to provide consent
  • self-identifying as having an unfulfilled wish for children
  • being able to use and access MyJourney (have an internet connection, suitable device and have an active email address)
  • speak English or Portuguese
  • be able to fill out online questionnaires

Exclusion Criteria:

  • diagnosed with a mental-health disorder within the last 2 years [self-reported]
  • currently receiving therapy for a clinically diagnosed mental-health disorder
  • individual or group therapy or peer support specifically related to their unfulfilled wish for children [self-reported]
  • unable to use MyJourney due to other health problems (e.g., vision impairments)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04850482


Locations
Layout table for location information
United Kingdom
Cardiff University
Cardiff, United Kingdom, CF10 3AT
Sponsors and Collaborators
Cardiff University
Portuguese Fertility Association
Fertility Network UK
Investigators
Layout table for investigator information
Principal Investigator: Beth Rowbottom School of Psychology, Cardiff University
Principal Investigator: Sofia Gameiro School of Psychology, Cardiff University
Additional Information:
Publications:
Layout table for additonal information
Responsible Party: Sofia Gameiro, Principal Investigator, Cardiff University
ClinicalTrials.gov Identifier: NCT04850482    
Other Study ID Numbers: EC.20.10.13.6082
First Posted: April 20, 2021    Key Record Dates
Last Update Posted: August 3, 2021
Last Verified: August 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Sofia Gameiro, Cardiff University:
Well being
Unfulfilled wish for children
Self-Help
Online intervention
Involuntary childlessness